Does the media refer more to TMO or ILMN?

In the previous week, Illumina had 6 more articles in the media than Thermo Fisher Scientific. MarketBeat recorded 41 mentions for Illumina and 35 mentions for Thermo Fisher Scientific. Thermo Fisher Scientific's average media sentiment score of 1.22 beat Illumina's score of 0.79 indicating that Thermo Fisher Scientific is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Thermo Fisher Scientific 28 Very Positive mention(s) 5 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Illumina 22 Very Positive mention(s) 7 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 3 Very Negative mention(s) Positive

Does the media prefer MEDP or TMO?

In the previous week, Thermo Fisher Scientific had 24 more articles in the media than Medpace. MarketBeat recorded 35 mentions for Thermo Fisher Scientific and 11 mentions for Medpace. Medpace's average media sentiment score of 1.38 beat Thermo Fisher Scientific's score of 1.22 indicating that Medpace is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Medpace 10 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Thermo Fisher Scientific 28 Very Positive mention(s) 5 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to TMO or A?

In the previous week, Thermo Fisher Scientific had 18 more articles in the media than Agilent Technologies. MarketBeat recorded 35 mentions for Thermo Fisher Scientific and 17 mentions for Agilent Technologies. Thermo Fisher Scientific's average media sentiment score of 1.22 beat Agilent Technologies' score of 0.73 indicating that Thermo Fisher Scientific is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Thermo Fisher Scientific 28 Very Positive mention(s) 5 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Agilent Technologies 6 Very Positive mention(s) 1 Positive mention(s) 9 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor TMO or AMN?

In the previous week, Thermo Fisher Scientific had 28 more articles in the media than AMN Healthcare Services. MarketBeat recorded 35 mentions for Thermo Fisher Scientific and 7 mentions for AMN Healthcare Services. Thermo Fisher Scientific's average media sentiment score of 1.22 beat AMN Healthcare Services' score of 0.73 indicating that Thermo Fisher Scientific is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Thermo Fisher Scientific 28 Very Positive mention(s) 5 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive AMN Healthcare Services 3 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor BIO or TMO?

In the previous week, Thermo Fisher Scientific had 29 more articles in the media than Bio-Rad Laboratories. MarketBeat recorded 35 mentions for Thermo Fisher Scientific and 6 mentions for Bio-Rad Laboratories. Thermo Fisher Scientific's average media sentiment score of 1.22 beat Bio-Rad Laboratories' score of 0.96 indicating that Thermo Fisher Scientific is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bio-Rad Laboratories 3 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Thermo Fisher Scientific 28 Very Positive mention(s) 5 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Thermo Fisher Scientific (TMO) Competitors

$605.29 +2.27 (+0.38%)

As of 02:09 PM Eastern

Compare

TMO vs. ILMN, MEDP, A, AMN, and BIO

Should you buy Thermo Fisher Scientific stock or one of its competitors? Thermo Fisher Scientific's main competitors and comparable companies include Illumina (ILMN), Medpace (MEDP), Agilent Technologies (A), AMN Healthcare Services (AMN), and Bio-Rad Laboratories (BIO). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare" sector.

How does Thermo Fisher Scientific compare to Illumina?

Thermo Fisher Scientific (NYSE:TMO) and Illumina (NASDAQ:ILMN) are both large-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, media sentiment, earnings, dividends, analyst recommendations, risk, valuation and institutional ownership.

Thermo Fisher Scientific currently has a consensus target price of $624.64, suggesting a potential upside of 3.20%. Illumina has a consensus target price of $199.13, suggesting a potential downside of 4.07%. Given Thermo Fisher Scientific's stronger consensus rating and higher probable upside, equities analysts plainly believe Thermo Fisher Scientific is more favorable than Illumina.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Thermo Fisher Scientific	2 Sell rating(s)	5 Hold rating(s)	17 Buy rating(s)	2 Strong Buy rating(s)	2.73
Illumina	2 Sell rating(s)	6 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.44

Illumina has a net margin of 18.36% compared to Thermo Fisher Scientific's net margin of 15.04%. Illumina's return on equity of 29.84% beat Thermo Fisher Scientific's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Thermo Fisher Scientific	15.04%	17.09%	8.12%
Illumina	18.36%	29.84%	12.17%

Thermo Fisher Scientific has a beta of 0.85, suggesting that its share price is 15% less volatile than the broader market. Comparatively, Illumina has a beta of 1.46, suggesting that its share price is 46% more volatile than the broader market.

In the previous week, Illumina had 6 more articles in the media than Thermo Fisher Scientific. MarketBeat recorded 41 mentions for Illumina and 35 mentions for Thermo Fisher Scientific. Thermo Fisher Scientific's average media sentiment score of 1.22 beat Illumina's score of 0.79 indicating that Thermo Fisher Scientific is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Thermo Fisher Scientific	28 Very Positive mention(s)	5 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Illumina	22 Very Positive mention(s)	7 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	3 Very Negative mention(s)	Positive

89.2% of Thermo Fisher Scientific shares are held by institutional investors. Comparatively, 89.4% of Illumina shares are held by institutional investors. 0.3% of Thermo Fisher Scientific shares are held by insiders. Comparatively, 2.9% of Illumina shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Thermo Fisher Scientific has higher revenue and earnings than Illumina. Thermo Fisher Scientific is trading at a lower price-to-earnings ratio than Illumina, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Thermo Fisher Scientific	$46.34B	4.83	$6.70B	$18.59	32.56
Illumina	$4.34B	7.22	$850M	$5.36	38.73

Summary

Illumina beats Thermo Fisher Scientific on 9 of the 17 factors compared between the two stocks.

How does Thermo Fisher Scientific compare to Medpace?

Medpace (NASDAQ:MEDP) and Thermo Fisher Scientific (NYSE:TMO) are both large-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, risk, dividends, valuation, media sentiment, earnings, analyst recommendations and profitability.

Thermo Fisher Scientific has higher revenue and earnings than Medpace. Thermo Fisher Scientific is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medpace	$2.53B	6.41	$451.12M	$17.06	34.06
Thermo Fisher Scientific	$46.34B	4.83	$6.70B	$18.59	32.56

Medpace has a net margin of 17.67% compared to Thermo Fisher Scientific's net margin of 15.04%. Medpace's return on equity of 110.15% beat Thermo Fisher Scientific's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Medpace	17.67%	110.15%	24.84%
Thermo Fisher Scientific	15.04%	17.09%	8.12%

Medpace has a beta of 1.15, suggesting that its stock price is 15% more volatile than the broader market. Comparatively, Thermo Fisher Scientific has a beta of 0.85, suggesting that its stock price is 15% less volatile than the broader market.

Medpace presently has a consensus target price of $595.20, suggesting a potential upside of 2.42%. Thermo Fisher Scientific has a consensus target price of $624.64, suggesting a potential upside of 3.20%. Given Thermo Fisher Scientific's stronger consensus rating and higher possible upside, analysts clearly believe Thermo Fisher Scientific is more favorable than Medpace.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medpace	0 Sell rating(s)	9 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.25
Thermo Fisher Scientific	2 Sell rating(s)	5 Hold rating(s)	17 Buy rating(s)	2 Strong Buy rating(s)	2.73

In the previous week, Thermo Fisher Scientific had 24 more articles in the media than Medpace. MarketBeat recorded 35 mentions for Thermo Fisher Scientific and 11 mentions for Medpace. Medpace's average media sentiment score of 1.38 beat Thermo Fisher Scientific's score of 1.22 indicating that Medpace is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Medpace	10 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Thermo Fisher Scientific	28 Very Positive mention(s)	5 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

78.0% of Medpace shares are held by institutional investors. Comparatively, 89.2% of Thermo Fisher Scientific shares are held by institutional investors. 20.5% of Medpace shares are held by company insiders. Comparatively, 0.3% of Thermo Fisher Scientific shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Thermo Fisher Scientific beats Medpace on 9 of the 17 factors compared between the two stocks.

How does Thermo Fisher Scientific compare to Agilent Technologies?

Thermo Fisher Scientific (NYSE:TMO) and Agilent Technologies (NYSE:A) are both large-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, analyst recommendations, profitability, earnings, valuation and media sentiment.

Thermo Fisher Scientific currently has a consensus target price of $624.64, indicating a potential upside of 3.20%. Agilent Technologies has a consensus target price of $170.33, indicating a potential upside of 17.16%. Given Agilent Technologies' stronger consensus rating and higher probable upside, analysts clearly believe Agilent Technologies is more favorable than Thermo Fisher Scientific.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Thermo Fisher Scientific	2 Sell rating(s)	5 Hold rating(s)	17 Buy rating(s)	2 Strong Buy rating(s)	2.73
Agilent Technologies	0 Sell rating(s)	5 Hold rating(s)	14 Buy rating(s)	1 Strong Buy rating(s)	2.80

In the previous week, Thermo Fisher Scientific had 18 more articles in the media than Agilent Technologies. MarketBeat recorded 35 mentions for Thermo Fisher Scientific and 17 mentions for Agilent Technologies. Thermo Fisher Scientific's average media sentiment score of 1.22 beat Agilent Technologies' score of 0.73 indicating that Thermo Fisher Scientific is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Thermo Fisher Scientific	28 Very Positive mention(s)	5 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Agilent Technologies	6 Very Positive mention(s)	1 Positive mention(s)	9 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Thermo Fisher Scientific pays an annual dividend of $1.88 per share and has a dividend yield of 0.3%. Agilent Technologies pays an annual dividend of $1.02 per share and has a dividend yield of 0.7%. Thermo Fisher Scientific pays out 10.1% of its earnings in the form of a dividend. Agilent Technologies pays out 20.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Thermo Fisher Scientific has raised its dividend for 8 consecutive years and Agilent Technologies has raised its dividend for 9 consecutive years. Agilent Technologies is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Thermo Fisher Scientific has higher revenue and earnings than Agilent Technologies. Agilent Technologies is trading at a lower price-to-earnings ratio than Thermo Fisher Scientific, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Thermo Fisher Scientific	$46.34B	4.83	$6.70B	$18.59	32.56
Agilent Technologies	$7.37B	5.56	$1.30B	$5.08	28.62

Thermo Fisher Scientific has a beta of 0.85, meaning that its stock price is 15% less volatile than the broader market. Comparatively, Agilent Technologies has a beta of 1.24, meaning that its stock price is 24% more volatile than the broader market.

Agilent Technologies has a net margin of 19.53% compared to Thermo Fisher Scientific's net margin of 15.04%. Agilent Technologies' return on equity of 24.45% beat Thermo Fisher Scientific's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Thermo Fisher Scientific	15.04%	17.09%	8.12%
Agilent Technologies	19.53%	24.45%	13.09%

89.2% of Thermo Fisher Scientific shares are held by institutional investors. Comparatively, 87.4% of Agilent Technologies shares are held by institutional investors. 0.3% of Thermo Fisher Scientific shares are held by insiders. Comparatively, 0.2% of Agilent Technologies shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Thermo Fisher Scientific beats Agilent Technologies on 11 of the 20 factors compared between the two stocks.

How does Thermo Fisher Scientific compare to AMN Healthcare Services?

Thermo Fisher Scientific (NYSE:TMO) and AMN Healthcare Services (NYSE:AMN) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, profitability, media sentiment, institutional ownership, dividends, valuation and risk.

Thermo Fisher Scientific pays an annual dividend of $1.88 per share and has a dividend yield of 0.3%. AMN Healthcare Services pays an annual dividend of $1.20 per share and has a dividend yield of 3.5%. Thermo Fisher Scientific pays out 10.1% of its earnings in the form of a dividend. AMN Healthcare Services pays out 44.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Thermo Fisher Scientific has increased its dividend for 8 consecutive years.

89.2% of Thermo Fisher Scientific shares are owned by institutional investors. Comparatively, 99.2% of AMN Healthcare Services shares are owned by institutional investors. 0.3% of Thermo Fisher Scientific shares are owned by insiders. Comparatively, 1.1% of AMN Healthcare Services shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Thermo Fisher Scientific has a net margin of 15.04% compared to AMN Healthcare Services' net margin of 3.06%. AMN Healthcare Services' return on equity of 19.92% beat Thermo Fisher Scientific's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Thermo Fisher Scientific	15.04%	17.09%	8.12%
AMN Healthcare Services	3.06%	19.92%	5.93%

Thermo Fisher Scientific has a beta of 0.85, meaning that its stock price is 15% less volatile than the broader market. Comparatively, AMN Healthcare Services has a beta of 0.38, meaning that its stock price is 62% less volatile than the broader market.

In the previous week, Thermo Fisher Scientific had 28 more articles in the media than AMN Healthcare Services. MarketBeat recorded 35 mentions for Thermo Fisher Scientific and 7 mentions for AMN Healthcare Services. Thermo Fisher Scientific's average media sentiment score of 1.22 beat AMN Healthcare Services' score of 0.73 indicating that Thermo Fisher Scientific is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Thermo Fisher Scientific	28 Very Positive mention(s)	5 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
AMN Healthcare Services	3 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Thermo Fisher Scientific currently has a consensus target price of $624.64, indicating a potential upside of 3.20%. AMN Healthcare Services has a consensus target price of $31.43, indicating a potential downside of 8.34%. Given Thermo Fisher Scientific's stronger consensus rating and higher probable upside, research analysts clearly believe Thermo Fisher Scientific is more favorable than AMN Healthcare Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Thermo Fisher Scientific	2 Sell rating(s)	5 Hold rating(s)	17 Buy rating(s)	2 Strong Buy rating(s)	2.73
AMN Healthcare Services	2 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.22

Thermo Fisher Scientific has higher revenue and earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than Thermo Fisher Scientific, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Thermo Fisher Scientific	$46.34B	4.83	$6.70B	$18.59	32.56
AMN Healthcare Services	$3.43B	0.39	-$95.70M	$2.68	12.79

Summary

Thermo Fisher Scientific beats AMN Healthcare Services on 16 of the 20 factors compared between the two stocks.

How does Thermo Fisher Scientific compare to Bio-Rad Laboratories?

Bio-Rad Laboratories (NYSE:BIO) and Thermo Fisher Scientific (NYSE:TMO) are both large-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, risk, earnings, dividends, valuation, analyst recommendations, institutional ownership and media sentiment.

In the previous week, Thermo Fisher Scientific had 29 more articles in the media than Bio-Rad Laboratories. MarketBeat recorded 35 mentions for Thermo Fisher Scientific and 6 mentions for Bio-Rad Laboratories. Thermo Fisher Scientific's average media sentiment score of 1.22 beat Bio-Rad Laboratories' score of 0.96 indicating that Thermo Fisher Scientific is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bio-Rad Laboratories	3 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Thermo Fisher Scientific	28 Very Positive mention(s)	5 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Thermo Fisher Scientific has higher revenue and earnings than Bio-Rad Laboratories. Thermo Fisher Scientific is trading at a lower price-to-earnings ratio than Bio-Rad Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bio-Rad Laboratories	$2.59B	3.89	$759.90M	$8.25	45.69
Thermo Fisher Scientific	$46.34B	4.83	$6.70B	$18.59	32.56

Thermo Fisher Scientific has a net margin of 15.04% compared to Bio-Rad Laboratories' net margin of 8.59%. Thermo Fisher Scientific's return on equity of 17.09% beat Bio-Rad Laboratories' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bio-Rad Laboratories	8.59%	3.54%	2.48%
Thermo Fisher Scientific	15.04%	17.09%	8.12%

Bio-Rad Laboratories presently has a consensus target price of $343.33, indicating a potential downside of 8.92%. Thermo Fisher Scientific has a consensus target price of $624.64, indicating a potential upside of 3.20%. Given Thermo Fisher Scientific's stronger consensus rating and higher possible upside, analysts clearly believe Thermo Fisher Scientific is more favorable than Bio-Rad Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bio-Rad Laboratories	0 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.20
Thermo Fisher Scientific	2 Sell rating(s)	5 Hold rating(s)	17 Buy rating(s)	2 Strong Buy rating(s)	2.73

Bio-Rad Laboratories has a beta of 1.07, meaning that its stock price is 7% more volatile than the broader market. Comparatively, Thermo Fisher Scientific has a beta of 0.85, meaning that its stock price is 15% less volatile than the broader market.

65.2% of Bio-Rad Laboratories shares are held by institutional investors. Comparatively, 89.2% of Thermo Fisher Scientific shares are held by institutional investors. 30.3% of Bio-Rad Laboratories shares are held by company insiders. Comparatively, 0.3% of Thermo Fisher Scientific shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Thermo Fisher Scientific beats Bio-Rad Laboratories on 14 of the 17 factors compared between the two stocks.

Get Thermo Fisher Scientific News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TMO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TMO vs. The Competition

Export

Metric	Thermo Fisher Scientific	Life Sciences Tools & Services Industry	Healthcare Sector	NYSE Exchange
Market Cap	$223.82B	$9.74B	$7.15B	$23.32B
Dividend Yield	0.31%	1.47%	2.54%	3.73%
P/E Ratio	32.56	65.55	271.90	28.78
Price / Sales	4.83	297.38	697.54	96.54
Price / Cash	20.19	26.85	77.07	33.53
Price / Book	4.26	5.26	10.81	4.76
Net Income	$6.70B	$56.67B	$3.48B	$1.07B
7 Day Performance	-0.50%	-2.75%	-0.91%	-0.76%
1 Month Performance	2.05%	0.12%	2.70%	-2.10%
1 Year Performance	25.11%	24.00%	21.40%	11.88%

Thermo Fisher Scientific Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TMO Thermo Fisher Scientific	4.2516 of 5 stars	$605.29 +0.4%	$624.64 +3.2%	+23.9%	$223.82B	$46.34B	32.56	125,000	Positive News Analyst Upgrade
ILMN Illumina	2.2646 of 5 stars	$213.63 -0.9%	$188.40 -11.8%	+115.0%	$32.26B	$4.34B	39.86	8,650	Analyst Forecast
MEDP Medpace	3.3677 of 5 stars	$593.99 -1.1%	$584.18 -1.7%	+20.1%	$16.58B	$2.53B	34.82	6,200	Positive News
A Agilent Technologies	4.6161 of 5 stars	$153.79 0.0%	$170.33 +10.8%	+14.6%	$43.43B	$6.95B	30.27	18,100	Analyst Forecast
AMN AMN Healthcare Services	2.5154 of 5 stars	$34.23 -1.1%	$31.43 -8.2%	+61.0%	$1.33B	$3.43B	12.77	2,664

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:TMO) was last updated on 9/9/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Thermo Fisher Scientific (TMO) Competitors

TMO vs. ILMN, MEDP, A, AMN, and BIO

How does Thermo Fisher Scientific compare to Illumina?

Summary

How does Thermo Fisher Scientific compare to Medpace?

Summary

How does Thermo Fisher Scientific compare to Agilent Technologies?

Summary

How does Thermo Fisher Scientific compare to AMN Healthcare Services?

Summary

How does Thermo Fisher Scientific compare to Bio-Rad Laboratories?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TMO vs. The Competition

Thermo Fisher Scientific Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Thermo Fisher Scientific (TMO) Competitors

TMO vs. ILMN, MEDP, A, AMN, and BIO

How does Thermo Fisher Scientific compare to Illumina?

Do analysts rate TMO or ILMN?

Is TMO or ILMN more profitable?

Which has more volatility & risk, TMO or ILMN?

Does the media refer more to TMO or ILMN?

Do insiders & institutionals hold more shares of TMO or ILMN?

Which has better earnings and valuation, TMO or ILMN?

Summary

How does Thermo Fisher Scientific compare to Medpace?

Which has higher valuation and earnings, MEDP or TMO?

Is MEDP or TMO more profitable?

Which has more risk & volatility, MEDP or TMO?

Do analysts prefer MEDP or TMO?

Does the media prefer MEDP or TMO?

Do institutionals and insiders have more ownership in MEDP or TMO?

Summary

How does Thermo Fisher Scientific compare to Agilent Technologies?

Do analysts prefer TMO or A?

Does the media refer more to TMO or A?

Is TMO or A a better dividend stock?

Which has higher valuation & earnings, TMO or A?

Which has more risk and volatility, TMO or A?

Is TMO or A more profitable?

Do institutionals and insiders believe in TMO or A?

Summary

How does Thermo Fisher Scientific compare to AMN Healthcare Services?

Is TMO or AMN a better dividend stock?

Do insiders and institutionals have more ownership in TMO or AMN?

Is TMO or AMN more profitable?

Which has more risk and volatility, TMO or AMN?

Does the media favor TMO or AMN?

Do analysts prefer TMO or AMN?

Which has preferable earnings & valuation, TMO or AMN?

Summary

How does Thermo Fisher Scientific compare to Bio-Rad Laboratories?

Does the media favor BIO or TMO?

Which has stronger valuation and earnings, BIO or TMO?

Is BIO or TMO more profitable?

Do analysts prefer BIO or TMO?

Which has more risk and volatility, BIO or TMO?

Do insiders & institutionals hold more shares of BIO or TMO?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TMO vs. The Competition

Thermo Fisher Scientific Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools